Skip to content
Open access

Scop3P in 2026: an expanded proteomics-informed resource contextualizing phosphorylation sites through sequence, structure, mutation, and experimental provenance

Jul 2026 · bioRxiv · 0 citations · 44 references
Biology

TL;DR

A major update of Scop3P, a proteomics-informed knowledgebase that contextualizes human phosphorylation sites within integrated sequence, structural, biophysical, evolutionary, and mutational frameworks, and provides a scalable and provenance-aware resource for phosphosite interpretation, hypothesis generation, and data-driven modelling of phosphorylation-dependent regulation.

Abstract

Protein phosphorylation is a central regulatory mechanism controlling protein activity, interactions, and cellular signalling, and its dysregulation is implicated in numerous diseases. Advances in mass spectrometry–based phosphoproteomics have led to a rapid expansion in the number of reported phosphorylation sites; however, interpretation of these data remains challenging due to fragmented evidence, limited structural context, and the lack of uniform experimental provenance across resources. Interpretation is further complicated by the fact that the biological meaning of reported phosphosites can vary substantially across tissues, cell lines, perturbations, and disease settings. Here, we present a major update of Scop3P, a proteomics-informed knowledgebase that contextualizes human phosphorylation sites within integrated sequence, structural, biophysical, evolutionary, and mutational frameworks. The current release incorporates uniformly reprocessed human phosphoproteomics data from 116 PRIDE datasets alongside curated UniProt annotations, retaining peptide-spectrum matches, site localization confidence, and direct links to primary mass spectrometry evidence via Universal Spectrum Identifiers. This integration yields 152,350 unique serine, threonine, and tyrosine phosphorylation sites across 16,533 human proteins, supported by full experimental provenance. Beyond site identification, Scop3P provides residue-level contextual annotations derived from experimentally determined protein structures and proteome-wide AlphaFold models, enabling near-complete structural coverage of phosphorylation sites. Structural context is further complemented by residue-level biophysical, evolutionary, and mutational annotations, supporting integrated assessment of phosphorylation in functional and disease-related settings. The current release also introduces residue interaction network representations derived from AlphaFold-predicted structures, capturing spatial connectivity and local interaction environments of phosphorylation and mutation sites. A redesigned web interface enables interactive exploration through coordinated 1D, 2D, 2.5D, and 3D visualizations, peptide-level coverage views, and direct access to original spectra via PRIDE. By bridging experimental phosphoproteomics with structural, functional, and disease-related context, Scop3P provides a scalable and provenance-aware resource for phosphosite interpretation, hypothesis generation, and data-driven modelling of phosphorylation-dependent regulation.

Read PDF

Similar papers

Open access Aug 2026

Scop3P-Toolkit: executable structure-aware workflows linking PTMs, peptides, and mutations to protein function

Scop3P-Toolkit is an open-source executable analytical environment for interactive analysis of PTMs, mutations, and proteomics-derived peptides in their structural context, providing transparent, accessible, and reproducible workflows for both computational and experimental researchers.

Adrián Díaz, Natalia Tichshenko, Boris Depoortere et al. · 0 citations
Open access Jul 2026

MSstatsBioNet: Integrating Statistical Analyses with Prior Knowledge Biomolecular Networks for Quantitative Proteomics and Phosphoproteomics

This manuscript automates the integration of biological network databases with MSstatsBioNet, a Bioconductor package that integrates MSstats, a family of open-source packages for detecting differentially abundant proteins, and INDRA, a system that extracts biomolecular networks from biomedical literature using text min...

Anthony Wu, Devon Kohler, Pruthvi Prakash Navada et al. · 0 citations
Open access Aug 2026

MetaDome 2027: a comprehensively updated resource for aggregating missense variant evidence across homologous human protein domains

The MetaDome 2027 update is presented, featuring a comprehensively updated dataset and GRCh38 support and showing how MetaDome helped reclassify a de novo missense VUS in RALA and identify 52,463 ClinVar missense VUS for which meta-domains supply otherwise unavailable pathogenic evidence.

Laurens Wiel, F. Ferraro, Jay Yu et al. · 0 citations
Review Open access Sep 2026

Proteoforms in Disease: Biomedical Applications of Top-Down Proteomics.

The evolving role of TDP in biomedical research is reviewed, highlighting studies that revealed proteoform-level alterations, identified candidate biomarkers, and advanced the understanding of the roles of proteoforms in human diseases.

Holden T. Rogers, Zachery R. Gregorich, Megan S. Gant et al. · 1 citation
Open access Sep 2026

SPLISOFORMS: a Structure-Resolved Knowledge Base of Alternative Splicing Isoforms

Background Alternative splicing expands the coding capacity of single genes into diverse protein families, and its dysregulation is a recognized hallmark of cancer. Despite this, the characterization of splice variants is largely restricted to sequence-level annotations. The functional consequences of an isoform, such...

Jakob Steuer, Abdullah Kahraman · 0 citations
#large language models Open access Sep 2026

Atlantis: An integrative database for human proteome structural and functional sites

Atlantis, a database that integrates structural and functional information at the human proteome residue level and a Model Context Protocol (MCP) connector allows the interrogation of the resource through Large Language Models (LLMs) or agentic frameworks for biomedical research.

Natalia De Oliveira Rosa, Piergiorgio Ferronato, M. Varisco et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.